Ribeiro Ramiro — SEC Form 4 filings
SEC reporting owner CIK 2013623. 9 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-03-04 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 6 filings — 57,453 shares, $948,771 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 42,544 shares @ $17.10 ($727,319) in EyePoint, Inc., filed 2026-01-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| EyePoint, Inc. (EYPT) | Chief Medical Officer | 9 | — | 7 legs · 57,453 sh · $948,771 | 20 |
Form 4 filings — Ribeiro Ramiro
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | EyePoint, Inc. (EYPT) | Option exercise (M): 2,437 @ $8.26 · Option exercise (M): 2,438 @ $8.26 · Sale (S): 2,437 @ $15 · Sale (S): 2,438 @ $15.02 · Option exercise (M): 2,437 (derivative) @ $0 · Option exercise (M): 2,438 (derivative) @ $0 | EDGAR |
| 2026-04-20 | 4 | EyePoint, Inc. (EYPT) | Option exercise (M): 2,437 @ $8.26 · Sale (S): 2,437 @ $15 · Option exercise (M): 2,437 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | EyePoint, Inc. (EYPT) | Option exercise (M): 2,438 @ $8.26 · Sale (S): 2,438 @ $17.87 · Option exercise (M): 2,438 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | EyePoint, Inc. (EYPT) | Option exercise (M): 2,437 @ $8.26 · Sale (S): 2,437 @ $15 · Option exercise (M): 2,437 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | EyePoint, Inc. (EYPT) | Option exercise (M): 29,250 @ $8.26 · Sale (S): 42,544 @ $17.10 · Option exercise (M): 29,250 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | EyePoint, Inc. (EYPT) | Option exercise (M): 19,667 @ $0 · Tax withholding (F): 6,373 @ $17.48 · Grant/award (A): 85,700 (derivative) @ $0 · Grant/award (A): 171,400 (derivative) @ $0 · Option exercise (M): 19,667 (derivative) @ $0 | EDGAR |
| 2025-11-12 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Sale (S): 2,722 @ $11.61 | EDGAR |
| 2025-01-07 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Grant/award (A): 59,000 (derivative) @ $0 · Grant/award (A): 117,000 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2013623 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →